|
CAR T-Cell Therapy for Non-Hodgkin’s lymphoma (NHL) Epidemiology Report 2022: Focus on United States, Germany, Spain, Italy, France, United Kingdom, and Japan 2019-2032 – ResearchAndMarkets.com
|
DUBLIN--(BUSINESS WIRE)--The "CAR T-Cell Therapy for Non-Hodgkin's lymphoma (NHL) - Epidemiology Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The CAR T-Cell Therapy for Non-Hodgkin's lymphoma (NHL) epidemiology report g...
Full "IntellAsia: Resources" article
|
|